Literature DB >> 3620697

Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients.

H K Nieuwenhuis, J W Akkerman, J J Sixma.   

Abstract

One hundred six patients with storage pool deficiency (SPD) were studied with respect to platelet count, bleeding time, total platelet ATP and ADP, platelet serotonin, and in vitro aggregation. The diagnosis of SPD was made on basis of a prolonged bleeding time, a decreased total platelet ADP, and a diminished level of serotonin. Fifty-one patients from 34 unrelated families had congenital SPD, and 55 patients had acquired SPD. Congenital SPD was a common disorder in patients with a lifelong bleeding tendency and a prolonged bleeding time. The frequency in this group of patients was 18%, about one-half the frequency of von Willebrand's disease (vWd). Twenty-three percent of all patients had normal aggregation responses to ADP, epinephrine, and collagen; 33% had aggregation tracings typical for a secretion defect; and 44% had miscellaneous aggregation abnormalities. These findings indicate that SPD is common, heterogeneous, and not necessarily associated with in vitro aggregation abnormalities.

Entities:  

Mesh:

Year:  1987        PMID: 3620697

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

Review 1.  [Significance of platelet function tests].

Authors:  Z Wolf; H Mani; E Lindhoff-Last
Journal:  Internist (Berl)       Date:  2010-09       Impact factor: 0.743

Review 2.  [Congenital thrombocytopathies].

Authors:  C M Kirchmaier; D Pillitteri
Journal:  Internist (Berl)       Date:  2010-09       Impact factor: 0.743

Review 3.  Molecular defects that affect platelet dense granules.

Authors:  Meral Gunay-Aygun; Marjan Huizing; William A Gahl
Journal:  Semin Thromb Hemost       Date:  2004-10       Impact factor: 4.180

Review 4.  Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics.

Authors:  Marjan Huizing; Amanda Helip-Wooley; Wendy Westbroek; Meral Gunay-Aygun; William A Gahl
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

5.  Guidelines on platelet function testing. The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force.

Authors: 
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

6.  Constitutively released adenosine diphosphate regulates proplatelet formation by human megakaryocytes.

Authors:  Alessandra Balduini; Christian Andrea Di Buduo; Alessandro Malara; Anna Lecchi; Paola Rebuzzini; Manuela Currao; Isabella Pallotta; Joseph A Jakubowski; Marco Cattaneo
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

7.  Use of a microchip flow-chamber system as a screening test for platelet storage pool disease.

Authors:  Hiroaki Minami; Keiji Nogami; Kenichi Ogiwara; Shoko Furukawa; Kazuya Hosokawa; Midori Shima
Journal:  Int J Hematol       Date:  2015-06-14       Impact factor: 2.490

8.  Risk factors for thrombosis in lupus patients.

Authors:  P Hasselaar; R H Derksen; L Blokzijl; M Hessing; H K Nieuwenhuis; B N Bouma; P G De Groot
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

9.  Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo.

Authors:  Gwenda J Graham; Qiansheng Ren; James R Dilks; Price Blair; Sidney W Whiteheart; Robert Flaumenhaft
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

10.  Molecular map of chromosome 19 including three genes affecting bleeding time: ep, ru, and bm.

Authors:  E P O'Brien; E K Novak; S A Keller; C Poirier; J L Guénet; R T Swank
Journal:  Mamm Genome       Date:  1994-06       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.